These findings demonstrate that CDKL5 undergoes LLPS, driven by a CTD region whose loss in distally truncated forms of the protein-by impairing LLPS and functional activity-may play a role in the molecular pathogenesis of CDD. The gene discussed is CDKL5; the disease is craniodiaphyseal dysplasia.